Shenling Baizhu granules

Developed for: colorectal adenoma
Investigated by: Affiliated Hospital of Nanjing University of Chinese Medicine · Beijing Friendship Hospital · Institute of Science, Beijing Tongrentang Co., Ltd. · Shanghai Jiao Tong University School of Medicine · Shuguang Hospital of Shanghai University of Traditional Chinese Medicine · Sixth Affiliated Hospital, Sun Yat-sen University
+2 more
· Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Yueyang Hospital of Integrated Traditional Chinese and Western Medicine

today NCT06930157 · Ph 4

2026202720282029

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT06930157	Nov 2025 → Dec 2028 expected	colorectal adenoma	Shanghai Jiao Tong University School of Medicine	Recruiting	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Shenling Baizhu granules	ClinicalTrials.gov intervention name — accepted as the source's own label NCT06930157 ↗
Modality	Traditional medicine (herbal / TCM)	“traditional Chinese medicine preparation” NCT06930157 ↗
Route	Oral	“Participants in the experimental group will take 6 g orally three times daily for 6 months” NCT06930157 ↗